Therapeutic strategy of untreated de novo acute myeloid leukemia in the elderly: the efficacy of continuous drip infusion with low dose cytarabine and etoposide (Q80203294)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 April 2007

Language	Label	Description	Also known as
English	Therapeutic strategy of untreated de novo acute myeloid leukemia in the elderly: the efficacy of continuous drip infusion with low dose cytarabine and etoposide	scientific article published on 24 April 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Therapeutic strategy of untreated de novo acute myeloid leukemia in the elderly: the efficacy of continuous drip infusion with low dose cytarabine and etoposide (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

based on heuristic

inferred from title

myeloid leukemia

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hisashi Tsurumi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Nobuhiro Kanemura

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Takeshi Hara

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Senji Kasahara

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Toshiki Yamada

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Michio Sawada

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Masami Oyama

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Hisataka Moriwaki

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

24 April 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

133

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

547-553

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Pretreatment prognostic factors and treatment outcome in elderly patients with de novo acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Low dose continuous infusion therapy with etoposide (VP-16) and cytosine arabinoside (Ara-C) for a patient with refractory acute myelogenous leukemia]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute myeloid leukemia: epidemiology and etiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low dose Ara-C for myelodysplastic syndromes: is it still a current therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How I treat older patients with AML

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of acute myeloid leukemia in elderly patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17453240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-007-0203-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453240%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80203294&oldid=2220839967"